The Effect of Horizant (Gabapentin Enacarbil) on Augmentation

Clinical trial NCT02642315 · COMPLETED

Trial details

NCT number: NCT02642315
Sponsor: University of Missouri-Columbia
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2016-01-01
Primary completion: 2019-05-06
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.